Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The iRhom2/ADAM17 Axis Attenuates Bacterial Uptake by Phagocytes in a Cell Autonomous Manner

A. Seifert, J. Wozniak, S. Düsterhöft, P. Kasparek, R. Sedlacek, S. Dreschers, TW. Orlikowsky, D. Yildiz, A. Ludwig

. 2020 ; 21 (17) : . [pub] 20200819

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012253

Grantová podpora
Dr1013/1-1 Deutsche Forschungsgemeinschaft
OP RDI CZ.1.05/2.1.00/19.0395 Ministry of Education, Youth and Science
OP RDI CZ.1.05/2.1.00/19.0395 European Regional Development Fund
Lu869/8-1 Deutsche Forschungsgemeinschaft

Uptake of bacteria by phagocytes is a crucial step in innate immune defence. Members of the disintegrin and metalloproteinase (ADAM) family critically control the immune response by limited proteolysis of surface expressed mediator molecules. Here, we investigated the significance of ADAM17 and its regulatory adapter molecule iRhom2 for bacterial uptake by phagocytes. Inhibition of metalloproteinase activity led to increased phagocytosis of pHrodo labelled Gram-negative and -positive bacteria (E. coli and S. aureus, respectively) by human and murine monocytic cell lines or primary phagocytes. Bone marrow-derived macrophages showed enhanced uptake of heat-inactivated and living E. coli when they lacked either ADAM17 or iRhom2 but not upon ADAM10-deficiency. In monocytic THP-1 cells, corresponding short hairpin RNA (shRNA)-mediated knockdown confirmed that ADAM17, but not ADAM10, promoted phagocytosis of E. coli. The augmented bacterial uptake occurred in a cell autonomous manner and was accompanied by increased release of the chemokine CXCL8, less TNFα release and only minimal changes in the surface expression of the receptors TNFR1, TLR6 and CD36. Inhibition experiments indicated that the enhanced bacterial phagocytosis after ADAM17 knockdown was partially dependent on TNFα-activity but not on CXCL8. This novel role of ADAM17 in bacterial uptake needs to be considered in the development of ADAM17 inhibitors as therapeutics.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012253
003      
CZ-PrNML
005      
20210507102655.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms21175978 $2 doi
035    __
$a (PubMed)32825187
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Seifert, Anke $u Institute of Molecular Pharmacology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany
245    14
$a The iRhom2/ADAM17 Axis Attenuates Bacterial Uptake by Phagocytes in a Cell Autonomous Manner / $c A. Seifert, J. Wozniak, S. Düsterhöft, P. Kasparek, R. Sedlacek, S. Dreschers, TW. Orlikowsky, D. Yildiz, A. Ludwig
520    9_
$a Uptake of bacteria by phagocytes is a crucial step in innate immune defence. Members of the disintegrin and metalloproteinase (ADAM) family critically control the immune response by limited proteolysis of surface expressed mediator molecules. Here, we investigated the significance of ADAM17 and its regulatory adapter molecule iRhom2 for bacterial uptake by phagocytes. Inhibition of metalloproteinase activity led to increased phagocytosis of pHrodo labelled Gram-negative and -positive bacteria (E. coli and S. aureus, respectively) by human and murine monocytic cell lines or primary phagocytes. Bone marrow-derived macrophages showed enhanced uptake of heat-inactivated and living E. coli when they lacked either ADAM17 or iRhom2 but not upon ADAM10-deficiency. In monocytic THP-1 cells, corresponding short hairpin RNA (shRNA)-mediated knockdown confirmed that ADAM17, but not ADAM10, promoted phagocytosis of E. coli. The augmented bacterial uptake occurred in a cell autonomous manner and was accompanied by increased release of the chemokine CXCL8, less TNFα release and only minimal changes in the surface expression of the receptors TNFR1, TLR6 and CD36. Inhibition experiments indicated that the enhanced bacterial phagocytosis after ADAM17 knockdown was partially dependent on TNFα-activity but not on CXCL8. This novel role of ADAM17 in bacterial uptake needs to be considered in the development of ADAM17 inhibitors as therapeutics.
650    _2
$a protein ADAM17 $x genetika $x metabolismus $7 D000072198
650    _2
$a zvířata $7 D000818
650    _2
$a antigeny CD36 $x genetika $x metabolismus $7 D018955
650    _2
$a kultivované buňky $7 D002478
650    _2
$a Escherichia coli $x patogenita $7 D004926
650    _2
$a lidé $7 D006801
650    _2
$a interleukin-8 $x metabolismus $7 D016209
650    _2
$a intracelulární signální peptidy a proteiny $x genetika $x metabolismus $7 D047908
650    _2
$a myši $7 D051379
650    _2
$a fagocyty $x metabolismus $x mikrobiologie $7 D010586
650    _2
$a fagocytóza $7 D010587
650    _2
$a RAW 264.7 buňky $7 D000067996
650    _2
$a receptory TNF - typ I $x genetika $x metabolismus $7 D047888
650    _2
$a Staphylococcus aureus $x patogenita $7 D013211
650    _2
$a THP-1 buňky $7 D000074084
650    _2
$a toll-like receptor 6 $x genetika $x metabolismus $7 D051216
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wozniak, Justyna $u Institute of Molecular Pharmacology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany
700    1_
$a Düsterhöft, Stefan $u Institute of Molecular Pharmacology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany
700    1_
$a Kasparek, Petr $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, 25250 Vestec, Czech Republic
700    1_
$a Sedlacek, Radislav $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, 25250 Vestec, Czech Republic
700    1_
$a Dreschers, Stephan $u Department of Neonatology, University Children's Hospital, 52074 Aachen, Germany
700    1_
$a Orlikowsky, Thorsten W $u Department of Neonatology, University Children's Hospital, 52074 Aachen, Germany
700    1_
$a Yildiz, Daniela $u Institute of Molecular Pharmacology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany $u Institute of Experimental and Clinical Pharmacology and Toxicology, PZMS, ZHMB, Saarland University, 66424 Homburg, Germany
700    1_
$a Ludwig, Andreas $u Institute of Molecular Pharmacology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 17 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32825187 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507102654 $b ABA008
999    __
$a ok $b bmc $g 1650592 $s 1132632
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 17 $e 20200819 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a Dr1013/1-1 $p Deutsche Forschungsgemeinschaft
GRA    __
$a OP RDI CZ.1.05/2.1.00/19.0395 $p Ministry of Education, Youth and Science
GRA    __
$a OP RDI CZ.1.05/2.1.00/19.0395 $p European Regional Development Fund
GRA    __
$a Lu869/8-1 $p Deutsche Forschungsgemeinschaft
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...